• FT: Vaccine makers race to fix vaccine supply issues

    13 days ago - By Green Light Biosciences

    GreenLight Biosciences explain to the Financial Times the vaccine supply issues for a Covid-19 vaccine.
    GreenLight Biosciences spoke to the Financial Times about the vaccine supply issues for the Covid-19 vaccine. An extract from the article is below:
    Andrey Zarur, head of GreenLight Biosciences, said ingredients stockpiled ahead of vaccine approvals would supply the first 1bn-2bn doses, but bottlenecks would emerge after that. Challenges include sourcing items ranging from DNA molecules to lipid nanoparticles - the microscopic oily droplets that deliver the vaccine's active mRNA...
    Read more ...

     

  • Mail Online: Vaccine roll out issues

    Mail Online: Vaccine roll out issues

    13 days ago - By Green Light Biosciences

    GreenLight Biosciences explain to the Mail Online about the vaccine roll out issues for a Covid-19 vaccine.
    GreenLight Biosciences spoke to Mail Online about the vaccine supply issues in rolling out the Covid-19 vaccine. An extract from the article is below:
    Andrey Zarur, chief executive of GreenLight BioSciences, a US company that works with mRNA used in the vaccine, told the publication that the availability of this product is ‘fairly restricted' in Europe. Plans for the vaccine roll out were thrown into yet more chaos last night after the Medicines and Healthcare products Regulatory...
    Read more ...